Home/Investors/Kyoto University Innovation Capital Co., Ltd.

Kyoto University Innovation Capital Co., Ltd.

Biotech Investor · 3 portfolio companies

Portfolio

3

Focus Areas

5

Top Stage

preclinical

Investment Focus

Regenerative Medicine Genetic Disorders Oncology Metabolic Disorders Endocrinology

Portfolio Companies

Company	Stage	Valuation	Focus
aceRNA Technology	preclinical	—	Regenerative Medicine, Genetic Disorders
FIMECS	preclinical	—	Oncology
Orizuru Therapeutics	phase-1	—	Metabolic Disorders, Endocrinology

Frequent Co-Investors

UTokyo Innovation Platform Co., Ltd.2 shared SMBC Venture Capital Co., Ltd.1 shared Mitsubishi UFJ Capital Co., Ltd.1 shared Takeda Pharmaceutical Co., Ltd.1 shared Cosmo Bio Co., Ltd.1 shared ANRI Co., Ltd.1 shared Nissay Capital Co., Ltd.1 shared Kiichiro Nakajima1 shared